TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling
Ming-Dian Wang,Hui-Ting Li,Li-Xia Peng,Yan Mei,Li-Sheng Zheng,Chang-Zhi Li,Dong-Fang Meng,Yan-Hong Lang,Liang Xu,Xing-Si Peng,Zhi-Jie Liu,De-Huan Xie,Ling-Ling Guo,Mao-Guang Ma,Liu-Yan Ding,Bi-Jun Huang,Yun Cao,Chao-Nan Qian
DOI: https://doi.org/10.1038/s41417-023-00716-w
IF: 5.854
2023-12-23
Cancer Gene Therapy
Abstract:Nasopharyngeal carcinoma (NPC) originates in the epithelial cells of the nasopharynx and is a common malignant tumor in southern China and Southeast Asia. Metastasis of NPC remains the main cause of death for NPC patients even though the tumor is sensitive to radiotherapy and chemotherapy. Here, we found that the transmembrane protein tetraspanin1 (TSPAN1) potently inhibited the in vitro migration and invasion, as well as, the in vivo metastasis of NPC cells via interacting with the IKBB protein. In addition, TSPAN1 was essential in preventing the overactivation of the NF-kB pathway in TSPAN1 overexpressing NPC cells. Furthermore, reduced TSPAN1 expression was associated with NPC metastasis and the poor prognosis of NPC patients. These results uncovered the suppressive role of TSPAN1 against NF-kB signaling in NPC cells for preventing NPC metastasis. Its therapeutic value warrants further investigation.
oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology